Thu, November 9, 2023

Michael Petusky Maintained (SRDX) at Buy with Increased Target to $71 on, Nov 9th, 2023

Michael Petusky of Barrington Research, Maintained "Surmodics, Inc." (SRDX) at Buy with Increased Target from $69 to $71 on, Nov 9th, 2023.

Michael has made no other calls on SRDX in the last 4 months.



There is 1 other peer that has a rating on SRDX. Out of the 1 peers that are also analyzing SRDX, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Mike Matson of "Needham" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, November 8th, 2023